Cyclophosphamide high dose
Webtitle = "Allogeneic Blood or Marrow Transplantation with High-Dose Post-Transplantation Cyclophosphamide for Acute Lymphoblastic Leukemia in Patients Age ≥55 Years", abstract = "Patients age ≥55 years with acute lymphoblastic leukemia (ALL) fare poorly with conventional chemotherapy, with a 5-year overall survival (OS) of ∼20%. WebJan 3, 2024 · De Jonge ME, Mathôt RA, Van Dam SM, et al. Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin. Cancer Chemother Pharmacol 2002; 50:251. English MW, Lowis SP, Peng B, et al. Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal …
Cyclophosphamide high dose
Did you know?
WebAug 23, 2024 · Available as. Tablets and injection. Cyclophosphamide is used to treat a variety of different cancers. It is also occasionally used to treat severe symptoms of … WebCyclophosphamide is used to treat breast cancer, lung cancer, leukaemia, lymphoma and myeloma. It may sometimes be used to treat other cancers. It is best to read this …
WebSelect search scope, currently: articles+ all catalog, articles, website, & more in one search; catalog books, media & more in the Stanford Libraries' collections; articles+ journal articles & other e-resources WebWhen used as the only oncolytic drug therapy, the initial course of cyclophosphamide for patients with no hematologic deficiency usually consists of 40 to 50 mg/kg given intravenously in divided doses over a period of 2 to 5 days. Other intravenous regimens include 10 to 15 mg/kg given every 7 to 10 days or 3 to 5 mg/kg twice weekly.
WebApr 1, 1984 · Abstract The Eastern Cooperative Oncology Group evaluated cyclophosphamide 600 mg/m2 intravenously daily X 4 (total dose each cycle 2400 … WebIn general, much lower doses of cyclophosphamide are used to treat vasculitis than are used to treat cancer. However, the doses of cyclophosphamide used to treat vasculitis …
WebJul 4, 2024 · National Center for Biotechnology Information
WebNov 28, 2024 · Usual Adult Dose for Malignant Disease. IV: When used alone, the initial dose for patients with no hematologic deficiency is 40 to 50 mg/kg IV in divided doses … tait bookWebhigh-dose cyclophosphamide in the treatment of poor- risk myeloma patients who in all but four instances had disease refractory to prior chemotherapy. The entry of patients previously treated with standard-dose cyclo- phosphamide regimens was encouraged, and over 50% of the patients had received this drug at lower doses. Methods twin peaks putlockerWebJul 15, 2002 · High-dose cyclophosphamide was well tolerated. Common side effects included nausea, vomiting, transient alopecia, and neutropenic fever. There were no deaths or documented fungal infections, although one patient was treated empirically with amphotericin B for persistent neutropenic fever. ta itcWebObjective: Glomerulonephritis is a severe manifestation of systemic lupus erythematosus (SLE) that is usually treated with an extended course of intravenous (IV) cyclophosphamide (CYC). Given the side effects of this regimen, we evaluated the efficacy and the toxicity of a course of low-dose IV CYC prescribed as a remission-inducing … tait call letter downloadWebAug 14, 2006 · High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis Demyelinating Disorders JAMA Neurology JAMA Network BackgroundHigh-dose cyclophosphamide is active in immune-mediated illnesses.ObjectiveTo describe the effects of high-dose cyclophosphamide on severe … tait buildersWebThe Eastern Cooperative Oncology Group evaluated cyclophosphamide 600 mg/m2 intravenously daily X 4 (total dose each cycle 2400 mg/m2) as an aggressive approach … tait buildingWebAug 11, 2024 · Dosages of Cyclophosphamide Dosage Forms and Strengths Powder for injection 500 mg 1 g 2 g Tablet 25 mg 50 mg Dosage Considerations – Should be Given … tait blum home team